Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Karayama

Showing results (111-120 of 194) with videos related to

Pageof 20
Sort By:
International Journal of Molecular Sciences|August 14, 2025
PAI-1 Inhibitor TM5441 Attenuates Emphysema and Airway Inflammation in a Murine Model of Chronic Obstructive Pulmonary DiseaseKyohei Oishi, Hideki Yasui, Yusuke Inoue, et al.
BMC Cancer|August 16, 2015
Management of brain metastasis with magnetic resonance imaging and stereotactic irradiation attenuated benefits of prophylactic cranial irradiation in patients with limited-stage small cell lung cancerYuichi Ozawa, Minako Omae, Masato Fujii, et al.
Respiratory Research|March 12, 2022
Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction modelHironao Hozumi, Masato Kono, Hirotsugu Hasegawa, et al.
Respiratory Research|April 5, 2022
Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional studyTakafumi Koyauchi, Yuzo Suzuki, Kazuki Sato, et al.
Respiratory Medicine|May 25, 2016
Increased levels of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in idiopathic pulmonary fibrosisMasato Kono, Yutaro Nakamura, Yoshiyuki Oyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid TumorsShunji Takahashi, Masato Karayama, Masato Takahashi, et al.
Scientific Reports|September 18, 2021
Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosisYuzo Suzuki, Kazutaka Mori, Yuya Aono, et al.
Scientific Reports|July 30, 2021
Diagnostic and prognostic significance of serum angiopoietin-1 and -2 concentrations in patients with pulmonary hypertensionNoriyuki Enomoto, Seiichiro Suzuki, Hironao Hozumi, et al.
Respiratory Research|January 10, 2024
Pan-cancer assessment of antineoplastic therapy-induced interstitial lung disease in patients receiving subsequent therapy immediately following immune checkpoint blockade therapyYoshihiro Kitahara, Yusuke Inoue, Hideki Yasui, et al.
Therapeutic Advances in Respiratory Disease|September 15, 2020
Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosisYuya Aono, Yutaro Nakamura, Masato Kono, et al.
Pageof 20

Showing results (111-120 of 194) with videos related to

Sort By:
Pageof 20
International Journal of Molecular Sciences|August 14, 2025
PAI-1 Inhibitor TM5441 Attenuates Emphysema and Airway Inflammation in a Murine Model of Chronic Obstructive Pulmonary DiseaseKyohei Oishi, Hideki Yasui, Yusuke Inoue, et al.
BMC Cancer|August 16, 2015
Management of brain metastasis with magnetic resonance imaging and stereotactic irradiation attenuated benefits of prophylactic cranial irradiation in patients with limited-stage small cell lung cancerYuichi Ozawa, Minako Omae, Masato Fujii, et al.
Respiratory Research|March 12, 2022
Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction modelHironao Hozumi, Masato Kono, Hirotsugu Hasegawa, et al.
Respiratory Research|April 5, 2022
Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional studyTakafumi Koyauchi, Yuzo Suzuki, Kazuki Sato, et al.
Respiratory Medicine|May 25, 2016
Increased levels of serum Wisteria floribunda agglutinin-positive Mac-2 binding protein in idiopathic pulmonary fibrosisMasato Kono, Yutaro Nakamura, Yoshiyuki Oyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Pharmacokinetics, Safety, and Efficacy of Trastuzumab Deruxtecan with Concomitant Ritonavir or Itraconazole in Patients with HER2-Expressing Advanced Solid TumorsShunji Takahashi, Masato Karayama, Masato Takahashi, et al.
Scientific Reports|September 18, 2021
Combined assessment of the GAP index and body mass index at antifibrotic therapy initiation for prognosis of idiopathic pulmonary fibrosisYuzo Suzuki, Kazutaka Mori, Yuya Aono, et al.
Scientific Reports|July 30, 2021
Diagnostic and prognostic significance of serum angiopoietin-1 and -2 concentrations in patients with pulmonary hypertensionNoriyuki Enomoto, Seiichiro Suzuki, Hironao Hozumi, et al.
Respiratory Research|January 10, 2024
Pan-cancer assessment of antineoplastic therapy-induced interstitial lung disease in patients receiving subsequent therapy immediately following immune checkpoint blockade therapyYoshihiro Kitahara, Yusuke Inoue, Hideki Yasui, et al.
Therapeutic Advances in Respiratory Disease|September 15, 2020
Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosisYuya Aono, Yutaro Nakamura, Masato Kono, et al.
Pageof 20